TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients
Stocks in this Quantisnow insightHealth Care
Historical context for HTFL
Across the 24 sessions after earlier HTFL headlines, the stock closed higher 13 times and lower 11 times, with a median move of 2.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | HTFL | SPY |
|---|---|---|---|
| Oct 20, 2026 | Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026 | +9.0% | +0.3% |
| Sep 9, 2026 | UBS resumed coverage on Heartflow with a new price target | -2.3% | -0.5% |
| Aug 28, 2026 | Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Halfand 1 other headline that session | -0.7% | -0.2% |
| Aug 14, 2026 | Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | +35.7% | -0.2% |
| Jul 31, 2026 | Robert W. Baird initiated coverage on Heartflow with a new price target | -2.3% | +0.7% |
| Jul 24, 2026 | Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026 | -2.0% | +0.1% |
Quantisnow market dataNASDAQ
HTFL
Heartflow Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2025
Get push alerts for HTFL
Full HTFL profile on Quantisnow Follow HTFL and get a push notification the moment its next story breaks.